Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2025/544 of 25 March 2025 amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof

Type Implementing Regulation

Publication 2025-04-22

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 3

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


I, the undersigned official veterinarian, hereby certify that: II.1. The germinal product storage centre ⁽¹⁾ described in box I.11 at which the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [in vivo derived embryos] ⁽²⁾ [in vitro produced embryos] ⁽²⁾ to be dispatched to the Union was/were stored: II.1.1. is located in a third country or territory, or zone thereof II.1.1.1. authorised for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [in vivo derived embryos] ⁽²⁾ [in vitro produced embryos] ⁽²⁾ [micromanipulated embryos] ⁽²⁾ of porcine animals and listed in Annex XI to Commission Implementing Regulation (EU) 2021/404; ⁽²⁾ either [II.1.1.2. where foot and mouth disease was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ^{(2) (3)} or [II.1.1.2. where foot and mouth disease was not reported for a period starting on the date //_ (dd/mm/yyyy) immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ either [II.1.1.3. where classical swine fever was not reported for at least 12 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ^{(2) (3)} or [II.1.1.3. where classical swine fever was not reported for a period starting on the date //_ (dd/mm/yyyy) immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] II.1.1.4. where infection with rinderpest virus and African swine fever were not reported for at least 12 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch; II.1.1.5. where no vaccination against infection with rinderpest virus and classical swine fever has been carried out for at least 12 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and ⁽²⁾ either [no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;] ⁽²⁾ or [vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;] II.1.2. is approved and listed by the competent authority of the third country or territory; II.1.3. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.] II.2. The [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ described in Part I is/are intended for artificial reproduction, and: II.2.1. has/have been [collected] ⁽²⁾ [produced] ⁽²⁾, [processed] ⁽²⁾ [stored] ⁽²⁾ [in a semen collection centre] ^{(2) (4)} [by an embryo collection team] ^{(2) (4)} [by an embryo production team] ^{(2) (4)} [and] ⁽²⁾ [processed] ⁽²⁾ [stored] ⁽²⁾ [in a germinal product processing establishment] ^{(2) (4)} and stored in a germinal product storage centre ⁽⁴⁾ complying with requirements set out in [Part 1] ⁽²⁾ [Part 2] ⁽²⁾ [Part 3] ⁽²⁾ [Part 4] ⁽²⁾ [Part 5] ⁽²⁾ of Annex I to Delegated Regulation (EU) 2020/686, and: ⁽²⁾ either [located in the third country or territory of dispatch to the Union;] ^{(2) (5)} and/or [located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ of porcine animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/692;] II.2.2. was/were moved to the germinal product storage centre described in box I.11 under conditions at least as strict as described in: ⁽²⁾ either [Model POR-SEM-A-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-SEM-B-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-OOCYTES-EMB-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-GP-PROCESSING-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-GP-STORAGE-ENTRY ⁽⁶⁾;] II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686; II.2.4. is/are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.2.5. is/are transported in a container which: II.2.5.1. was sealed and numbered prior to the date of dispatch from the germinal product storage centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(2) (7)} [II.2.5.3. has been filled in with a cryogenic agent which has not been previously used for other products;] ^{(2) (8)} [II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed; II.2.7. is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.] Notes ”Porcine animal” means a porcine animal as defined in Article 2, point (4), of Delegated Regulation (EU) 2020/686. This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of porcine animals, including when the Union is not the final destination of the semen, oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product storage centre of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos. Box reference I.17 : “Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only for a third country or territory, or zone thereof with opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽⁴⁾ Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en. ⁽⁵⁾ Only a third country or territory, or zone thereof listed in Annex XI to Implementing Regulation (EU) 2021/404 for semen of porcine animals and Member States. ⁽⁶⁾ The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or the from germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate. ⁽⁷⁾ Applicable for frozen semen, oocytes or embryos. ⁽⁸⁾ Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of porcine animals are placed and transported in one container.

I, the undersigned official veterinarian, hereby certify that: II.1. The germinal product storage centre ⁽¹⁾ described in box I.11 at which the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [in vivo derived embryos] ⁽²⁾ [in vitro produced embryos] ⁽²⁾ to be dispatched to the Union was/were stored: II.1.1. is located in a third country or territory, or zone thereof II.1.1.1. authorised for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [in vivo derived embryos] ⁽²⁾ [in vitro produced embryos] ⁽²⁾ [micromanipulated embryos] ⁽²⁾ of porcine animals and listed in Annex XI to Commission Implementing Regulation (EU) 2021/404; ⁽²⁾ either [II.1.1.2. where foot and mouth disease was not reported for at least 24 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ^{(2) (3)} or [II.1.1.2. where foot and mouth disease was not reported for a period starting on the date //_ (dd/mm/yyyy) immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ⁽²⁾ either [II.1.1.3. where classical swine fever was not reported for at least 12 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] ^{(2) (3)} or [II.1.1.3. where classical swine fever was not reported for a period starting on the date //_ (dd/mm/yyyy) immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch;] II.1.1.4. where infection with rinderpest virus and African swine fever were not reported for at least 12 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch; II.1.1.5. where no vaccination against infection with rinderpest virus and classical swine fever has been carried out for at least 12 months immediately prior to the date of [collection] ⁽²⁾ [production] ⁽²⁾ of the [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ and until the date of its/their dispatch, and no vaccinated animals entered into the third country or territory, or zone thereof during that period, and ⁽²⁾ either [no vaccination against foot and mouth disease has been carried out for the same period, and no vaccinated animals entered into the third country or territory, or zone thereof during that period;] ⁽²⁾ or [vaccination against foot and mouth disease has been carried out for the same period, or vaccinated animals entered into the third country or territory, or zone thereof during that period;] II.1.2. is approved and listed by the competent authority of the third country or territory; II.1.3. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 5 of Annex I to Commission Delegated Regulation (EU) 2020/686.] II.2. The [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ described in Part I is/are intended for artificial reproduction, and: II.2.1. has/have been [collected] ⁽²⁾ [produced] ⁽²⁾, [processed] ⁽²⁾ [stored] ⁽²⁾ [in a semen collection centre] ^{(2) (4)} [by an embryo collection team] ^{(2) (4)} [by an embryo production team] ^{(2) (4)} [and] ⁽²⁾ [processed] ⁽²⁾ [stored] ⁽²⁾ [in a germinal product processing establishment] ^{(2) (4)} and stored in a germinal product storage centre ⁽⁴⁾ complying with requirements set out in [Part 1] ⁽²⁾ [Part 2] ⁽²⁾ [Part 3] ⁽²⁾ [Part 4] ⁽²⁾ [Part 5] ⁽²⁾ of Annex I to Delegated Regulation (EU) 2020/686, and: ⁽²⁾ either [located in the third country or territory of dispatch to the Union;] ^{(2) (5)} and/or [located in …, and has/have been introduced into the third country or territory of dispatch to the Union under conditions at least as strict as for the entry into the Union of [semen] ⁽²⁾ [oocytes] ⁽²⁾ [embryos] ⁽²⁾ of porcine animals in accordance with Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/692;] II.2.2. was/were moved to the germinal product storage centre described in box I.11 under conditions at least as strict as described in: ⁽²⁾ either [Model POR-SEM-A-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-SEM-B-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-OOCYTES-EMB-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-GP-PROCESSING-ENTRY ⁽⁶⁾;] ⁽²⁾ and/or [Model POR-GP-STORAGE-ENTRY ⁽⁶⁾;] II.2.3. has/have been collected, processed and stored in accordance with animal health requirements set out in Annex III to Delegated Regulation (EU) 2020/686; II.2.4. is/are placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.2.5. is/are transported in a container which: II.2.5.1. was sealed and numbered prior to the date of dispatch from the germinal product storage centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.2.5.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(2) (7)} [II.2.5.3. has been filled in with a cryogenic agent which has not been previously used for other products;] ^{(2) (8)} [II.2.6. is/are placed in straws or other packages which are securely and hermetically sealed; II.2.7. is/are transported in a container where the different types are separated from each other by physical compartments or by being placed in secondary protective bags.] Notes ”Porcine animal” means a porcine animal as defined in Article 2, point (4), of Delegated Regulation (EU) 2020/686. This animal health certificate is intended for the entry into the Union of semen, oocytes and embryos of porcine animals, including when the Union is not the final destination of the semen, oocytes and embryos. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the germinal product storage centre of dispatch of the consignment of semen, oocytes and/or embryos. Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen, oocytes and/or embryos. Box reference I.17 : “Accompanying documents”: Number(s) of related original animal health certificate(s) shall correspond to the serial number of the individual official document(s) or animal health certificate(s) that accompanied the semen, oocytes and/or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or from the germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre described in box I.11. The original(s) of those document(s) or those animal health certificate(s) or the officially endorsed copies thereof shall be attached to this animal health certificate. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Specify if semen, in vivo derived embryos, in vivo derived oocytes, in vitro produced embryos or micromanipulated embryos. “Identification number”: Indicate identification number of each donor animal. “Identification mark”: Indicate mark on the straw or other packages where semen, oocytes and/or embryos of the consignment are placed. “Date of collection/production”: Indicate the date on which semen, oocytes and/or embryos of the consignment was/were collected or produced. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected, and/or of the embryo collection team and/or the embryo production team by which oocytes or embryos of the consignment were collected or produced. “Quantity”: Indicate number of straws or other packages with the same mark. Part II: ⁽¹⁾ Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en. ⁽²⁾ Delete if not applicable. ⁽³⁾ Only for a third country or territory, or zone thereof with opening date in accordance with column 9 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404. ⁽⁴⁾ Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en. ⁽⁵⁾ Only a third country or territory, or zone thereof listed in Annex XI to Implementing Regulation (EU) 2021/404 for semen of porcine animals and Member States. ⁽⁶⁾ The original(s) of the document(s) or the animal health certificate(s) or the officially endorsed copies of thereof that accompanied the semen, oocytes or embryos described in Part I from the semen collection centre where the semen was collected, and/or from the embryo collection team and/or the embryo production team by which the oocytes and/or embryos were collected or produced, and/or from the germinal product processing establishment where the semen, oocytes or embryos were processed and stored, and/or the from germinal product storage centre where the semen, oocytes or embryos were stored, to the germinal product storage centre of dispatch of the semen, oocytes and/or embryos described in box I.11 shall be attached to this animal health certificate. ⁽⁷⁾ Applicable for frozen semen, oocytes or embryos. ⁽⁸⁾ Applicable for consignments where semen, oocytes, in vivo derived embryos, in vitro produced embryos and micromanipulated embryos of porcine animals are placed and transported in one container.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 59 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF SEMEN OF EQUINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH REGULATION (EU) 2016/429 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL AND COMMISSION DELEGATED REGULATION (EU) 2020/692 AFTER 20 APRIL 2021, DISPATCHED FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “EQUI-SEM-A-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model EQUI-SEM-A-ENTRY	Certificate model EQUI-SEM-A-ENTRY	Certificate model EQUI-SEM-A-ENTRY	Certificate model EQUI-SEM-A-ENTRY
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned official veterinarian, hereby certify that: II.1. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals which originate: II.1.1. from a third country or territory, or zone thereof II.1.1.1. authorised for the entry into the Union of semen of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404; II.1.1.2. free from African horse sickness for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch in accordance with Article 22(2), point (a), of Delegated Regulation (EU) 2020/692, and where no systematic vaccination against African horse sickness has been carried out for at least 12 months immediately prior to the date of collection of the semen and until the date of its dispatch in accordance with Article 22(4), point (b), of that Delegated Regulation; II.1.1.3. where Venezuelan equine encephalomyelitis was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch; II.1.2. from an establishment in a third country or territory, or zone thereof: ⁽¹⁾ either [II.1.2.1. where infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of collection of the semen and until the date of its dispatch;] ⁽¹⁾ or [II.1.2.1. where infection with Burkholderia mallei (glanders) was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽¹⁾ either [II.1.2.2. where dourine was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch;] ⁽¹⁾ or [II.1.2.2. where dourine was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽¹⁾ either [II.1.2.3. where surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch.] ⁽¹⁾ or [II.1.2.3. where surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period.] II.2. The semen described in Part I was obtained from donor animals which originate, prior to the date of entering the semen collection centre, from establishments: II.2.1. in which ⁽¹⁾ either [surra (Trypanosoma evansi) has not been reported during the preceding 2 years prior to the date of collection of the semen;] ⁽¹⁾ or [surra (Trypanosoma evansi) has not been reported during the preceding 30 days prior to the date of collection of the semen and when the disease was reported in the establishments during the preceding 2 years prior to the date of collection of the semen, following the last outbreak, the establishments have remained under movement restrictions ⁽¹⁾ either [until the date on which the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishments;]] ⁽¹⁾ or [for at least 30 days from the date of cleaning and disinfection after the date on which the last animal of listed species in the establishments was either killed and destroyed or slaughtered.]] II.2.2. in which dourine has not been reported during the preceding 6 months prior to the date of collection of the semen, and ⁽¹⁾ either [dourine has not been reported in the establishments during the preceding 2 years prior to the date of collection of the semen;] ⁽¹⁾ or [dourine has been reported in the establishments during the preceding 2 years prior to the date of collection of the semen and following the last outbreak, the establishments have remained under movement restrictions ⁽¹⁾ either [until the date on which the remaining equine animals in the establishments, except castrated male equine animals, have been subjected to a test for dourine with the diagnostic method provided for in Part 8 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated;]] ⁽¹⁾ or [for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the premises were cleaned and disinfected;]] II.2.3. in which ⁽¹⁾ either [equine infectious anaemia has not been reported in the establishments during the preceding 12 months prior to the date of collection of the semen;] ⁽¹⁾ or [equine infectious anaemia has been reported in the establishments during the preceding 12 months prior to the date of collection of the semen and following the last outbreak, the establishments have remained under movement restrictions ⁽¹⁾ either [until the date on which the remaining equine animals in the establishments have been subjected to a test for equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions with a minimum interval of 3 months after the date on which the infected animals have been killed and destroyed or slaughtered and the establishments were cleaned and disinfected;]] ⁽¹⁾ or [for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the establishments were cleaned and disinfected;]] II.2.4. in which during 30 days immediately prior to the date of collection of the semen no equine animal has shown signs of infection with equine arteritis virus and of contagious equine metritis. II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen collection centre ⁽²⁾ which: II.3.1. is approved and listed by the competent authority of the third country or territory; II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686. II.4. The semen described in Part I was obtained from donor animals which; II.4.1. were not vaccinated against African horse sickness at least in 40 days immediately prior to the date of collection of the semen; II.4.2. were not vaccinated against Venezuelan equine encephalomyelitis at least in 60 days immediately prior to the date of collection of the semen; II.4.3. remained for at least 3 months immediately prior to the date of collection of the semen in a third country or territory, or zone thereof referred to in box I.7; II.4.4. for at least 30 days immediately prior to the date of collection of the semen and during the collection period: II.4.4.1. were kept in establishments not situated in a restricted zone established due to the occurrence of African horse sickness, infection with Burkholderia mallei (glanders) or of an emerging disease relevant for equine animals; II.4.4.2. were kept in establishments where Venezuelan equine encephalomyelitis, dourine, surra (Trypanosoma evansi), equine infectious anaemia, contagious equine metritis (Taylorella equigenitalis), infection with rabies virus and anthrax have not been reported; II.4.4.3. were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.4.1 or from establishments which do not meet the conditions referred to in point II.4.4.2; II.4.5. were not used for natural breeding during at least 30 days immediately prior to the date of the first semen collection and between the dates of the first sample referred to in points II.4.8.1, II.4.8.2 and/or II.4.8.3. and until the end of the collection period; II.4.6. did not show symptoms of transmissible diseases on the date of admission to the semen collection centre and on the date of collection of the semen; II.4.7. are individually identified as provided for in Article 21(2) of Delegated Regulation (EU) 2020/692; II.4.8. have been subjected to the following tests, referred to in Part 4, Chapter I, point 1(a), of Annex II, to Delegated Regulation (EU) 2020/686, as follows: ⁽³⁾ II.4.8.1. for infection with equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result; II.4.8.2. for infection with equine arteritis virus (EVA), ⁽¹⁾ either [II.4.8.2.1. a serum neutralisation test with a negative result at a serum dilution of one in four;] ⁽¹⁾ and/or [II.4.8.2.2. a virus isolation test, polymerase chain reaction (PCR) or real-time PCR with a negative result on an aliquot of the entire semen of the donor stallion;] II.4.8.3. for contagious equine metritis (CEM), an agent identification test carried out on three specimens (swabs) taken from the donor stallion on two occasions with an interval of not less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis; The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor stallion and were placed in a transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory where they were subjected with a negative result to a test for: ⁽¹⁾ either [II.4.8.3.1. the isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport;] ⁽¹⁾ and/or [II.4.8.3.2. the detection of the genome of Taylorella equigenitalis by PCR or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal;] II.4.9. were subjected with the results specified in point II.4.8 in each case to at least one of the following testing programmes detailed in Part 4, Chapter I, points 1(b)(i), (ii) and (iii), of Annex II, to Delegated Regulation (EU) 2020/686: ⁽⁴⁾ [II.4.9.1. The donor stallion was continuously resident at the semen collection centre for at least 30 days immediately prior to the date of the first collection and during the period of collection of the semen described in Part I, and no equine animal in the semen collection centre came during that time into direct contact with equine animals of lower health status than the donor stallion. The tests described in point II.4.8 were carried out on samples taken ⁽⁵⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days immediately prior to the first semen collection.] ⁽⁴⁾ [II.4.9.2. The donor stallion was resident at the semen collection centre for at least 30 days immediately prior to the date of the first collection and during the period of collection of the semen described in Part I, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days during the collection period, or other equine animals in the semen collection centre came into direct contact with equine animals of a lower health status than the donor stallion. The tests described in point II.4.8 were carried out on samples taken ⁽⁵⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days immediately prior to the date of the first collection, and during the period of collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen, the donor stallion was subjected to the tests described in point II.4.8, as follows: (a) for equine infectious anaemia, one of the tests described in point II.4.8.1 was last carried out on a sample of blood taken ⁽⁵⁾ not more than 90 days prior to the date of collection of the semen described in Part I; (b) for infection with equine arteritis virus, one of the tests described ⁽¹⁾ either [in point II.4.8.2 was last carried out on a sample taken ⁽⁵⁾ not more than 30 days immediately prior to the date of collection of the semen described in Part I;] ⁽¹⁾ or [in point II.4.8.2.2, in case the non-shedder state of a donor stallion seropositive for infection with equine arteritis virus is confirmed, was carried out on an aliquot of the entire semen of the donor stallion taken ⁽⁵⁾ not more than 6 months prior to the date of collection of the semen described in Part I, and a blood sample taken ⁽⁵⁾ from the donor stallion during the last 6 months reacted with a positive result in a serum neutralisation test for infection with equine arteritis virus at a serum dilution of more than one in four;] (c) for contagious equine metritis, the tests described in point II.4.8.3 were last carried out on three specimens (swabs) taken ⁽⁵⁾ not more than 60 days immediately prior to the date of the collection of the semen described in Part I ⁽¹⁾ either [on two occasions.]] ⁽¹⁾ or [on a single occasion and subjected to a PCR or real-time PCR.]] ⁽⁴⁾ [II.4.9.3. The donor stallion did not meet the conditions set out in Part 4, Chapter I, points 1(b)(i) and (ii), of Annex II to Delegated Regulation (EU) 2020/686 and the semen was collected for the entry into the Union as frozen semen. The tests described in points II.4.8.1, II.4.8.2 and II.4.8.3 were carried out on samples taken ⁽⁵⁾ from the donor stallion at least once a year at the beginning of the breeding season, and the tests described in points II.4.8.1 and II.4.8.3 were carried out on samples taken ⁽⁵⁾ from the donor stallion during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and prior to the date of removal of the semen from the semen collection centre, not less than 14 days and not more than 90 days after the date of collection of the semen described in Part I, and ⁽¹⁾ either [the tests for infection with equine arteritis virus described in point II.4.8.2 were carried out on samples taken ⁽⁵⁾ during the storage period of the semen of a minimum of 30 days from the date of the collection of the semen and prior to the date of removal of the semen from the semen collection centre or used, not less than 14 days and not more than 90 days after the date of the collection of the semen described in Part I.]] ⁽¹⁾ or [the non-shedder state of a donor stallion seropositive for infection with equine arteritis virus was confirmed by virus isolation test, PCR or real-time PCR carried out with a negative result on samples of an aliquot of the entire semen of the donor stallion taken ⁽⁵⁾ twice a year at an interval of at least 4 months, and the donor stallion reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for infection with equine arteritis virus.]] II.4.10. underwent the testing provided for in point II.4.9 on samples taken on the following dates: Identification of semen Test programme Start date ⁽⁵⁾ Date of sampling for health tests ⁽⁵⁾ Donor residence Semen collection EIA II.4.8.1 EVA II.4.8.2 CEM II.4.8.3 Blood sample Semen sample 1. sample 2. sample II.5. The semen described in Part I: II.5.1. has been collected, processed and stored in accordance with animal health requirements set out in Part 1, points 1 and 2, of Annex III to Delegated Regulation (EU) 2020/686; II.5.2. is placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.5.3. is transported in a container which: II.5.3.1. was sealed and numbered prior to the date of dispatch from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(1) (6)} [II.5.3.3. has been filled in with a cryogenic agent which has not been previously used for other products.] ^{(1) (7)} [II.6. Where antibiotic(s) were added to the semen: II.6.1. The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: ⁽⁸⁾ … ; II.6.2. Immediately after the addition of the antibiotic(s), and before any possible freezing, the diluted semen was kept at a temperature of at least 5 °C, or under a time-temperature regime with a documented equivalent bactericidal activity.] Notes This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: Indicate “Yes, see points II.4.9 and II.4.10”. Part II: Guidance for the completion of the table in point II.4.10: Abbreviations: EIA-1 Equine infectious anaemia (EIA) testing first occasion EIA-2 EIA testing second occasion EVA-B1 Infection with equine arteritis virus (EVA) testing on a blood sample first occasion EVA-B2 EVA testing on a blood sample second occasion EVA-S1 EVA testing on a semen sample first occasion EVA-S2 EVA testing on a semen sample second occasion CEM-11 Contagious equine metritis (CEM) testing first occasion first sample CEM-12 CEM testing first occasion second sample taken 7 days after CEM-11 CEM-21 CEM testing second occasion first sample CEM-22 CEM testing second occasion second sample taken 7 days after CEM-21 Instructions: For each semen identified in column A of the table and indicated in box I.27, the test programme (point II.4.9.1, II.4.9.2 and/or II.4.9.3) shall be specified in column B of the table, and columns C and D of the table shall be completed with the dates required. The dates when samples were taken for laboratory testing prior to the first collection of the semen described in Part I as required by points II.4.9.1, II.4.9.2 and II.4.9.3, shall be entered in the upper line of columns 5 to 9 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the example below. The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.9.2 or II.4.9.3 shall be entered in the lower line of columns 5 to 9 of the table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below. Identification of semen Test programme Start date Date of sampling for health tests Donor residence Semen collection EIA II.4.8.1 EVA II.4.8.2 CEM II.4.8.3 Blood sample Semen sample 1.sample 2.sample A B C D EIA-1 EVA-B1 EVA-S1 CEM-11 CEM-12 EIA-2 EVA-B2 EVA-S2 CEM-21 CEM-22 ⁽¹⁾ Delete if not applicable. ⁽²⁾ Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽³⁾ The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equine animals and their semen, oocytes and embryos were introduced into Iceland from outside prior to and during the period the semen was collected. ⁽⁴⁾ Cross out the programmes that do not apply to the consignment. ⁽⁵⁾ Insert date in table in point II.4.10 (follow guidance in Part II of the Notes). ⁽⁶⁾ Applicable for frozen semen. ⁽⁷⁾ Mandatory attestation in case antibiotic(s) were added. ⁽⁸⁾ Insert the name(s) of the antibiotic(s) added and its (their) concentration or the commercial name of the semen diluent containing antibiotic(s).

I, the undersigned official veterinarian, hereby certify that: II.1. The semen described in Part I is intended for artificial reproduction and was obtained from donor animals which originate: II.1.1. from a third country or territory, or zone thereof II.1.1.1. authorised for the entry into the Union of semen of equine animals and listed in Annex XII to Commission Implementing Regulation (EU) 2021/404; II.1.1.2. free from African horse sickness for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch in accordance with Article 22(2), point (a), of Delegated Regulation (EU) 2020/692, and where no systematic vaccination against African horse sickness has been carried out for at least 12 months immediately prior to the date of collection of the semen and until the date of its dispatch in accordance with Article 22(4), point (b), of that Delegated Regulation; II.1.1.3. where Venezuelan equine encephalomyelitis was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch; II.1.2. from an establishment in a third country or territory, or zone thereof: ⁽¹⁾ either [II.1.2.1. where infection with Burkholderia mallei (glanders) was not reported for at least 36 months immediately prior to the date of collection of the semen and until the date of its dispatch;] ⁽¹⁾ or [II.1.2.1. where infection with Burkholderia mallei (glanders) was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽¹⁾ either [II.1.2.2. where dourine was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch;] ⁽¹⁾ or [II.1.2.2. where dourine was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period;] ⁽¹⁾ either [II.1.2.3. where surra (Trypanosoma evansi) was not reported for at least 24 months immediately prior to the date of collection of the semen and until the date of its dispatch.] ⁽¹⁾ or [II.1.2.3. where surra (Trypanosoma evansi) was not reported for at least 6 months immediately prior to the date of collection of the semen and until the date of its dispatch, and the Commission has recognised the surveillance programme carried out in breeding equine animals in the establishment of origin to demonstrate absence of infection during that period.] II.2. The semen described in Part I was obtained from donor animals which originate, prior to the date of entering the semen collection centre, from establishments: II.2.1. in which ⁽¹⁾ either [surra (Trypanosoma evansi) has not been reported during the preceding 2 years prior to the date of collection of the semen;] ⁽¹⁾ or [surra (Trypanosoma evansi) has not been reported during the preceding 30 days prior to the date of collection of the semen and when the disease was reported in the establishments during the preceding 2 years prior to the date of collection of the semen, following the last outbreak, the establishments have remained under movement restrictions ⁽¹⁾ either [until the date on which the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishments;]] ⁽¹⁾ or [for at least 30 days from the date of cleaning and disinfection after the date on which the last animal of listed species in the establishments was either killed and destroyed or slaughtered.]] II.2.2. in which dourine has not been reported during the preceding 6 months prior to the date of collection of the semen, and ⁽¹⁾ either [dourine has not been reported in the establishments during the preceding 2 years prior to the date of collection of the semen;] ⁽¹⁾ or [dourine has been reported in the establishments during the preceding 2 years prior to the date of collection of the semen and following the last outbreak, the establishments have remained under movement restrictions ⁽¹⁾ either [until the date on which the remaining equine animals in the establishments, except castrated male equine animals, have been subjected to a test for dourine with the diagnostic method provided for in Part 8 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed or slaughtered, or the infected entire male equine animals have been castrated;]] ⁽¹⁾ or [for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the premises were cleaned and disinfected;]] II.2.3. in which ⁽¹⁾ either [equine infectious anaemia has not been reported in the establishments during the preceding 12 months prior to the date of collection of the semen;] ⁽¹⁾ or [equine infectious anaemia has been reported in the establishments during the preceding 12 months prior to the date of collection of the semen and following the last outbreak, the establishments have remained under movement restrictions ⁽¹⁾ either [until the date on which the remaining equine animals in the establishments have been subjected to a test for equine infectious anaemia with the diagnostic method provided for in Part 9 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken on two occasions with a minimum interval of 3 months after the date on which the infected animals have been killed and destroyed or slaughtered and the establishments were cleaned and disinfected;]] ⁽¹⁾ or [for at least 30 days after the date on which the last equine animal in the establishments was either killed and destroyed or slaughtered, and the establishments were cleaned and disinfected;]] II.2.4. in which during 30 days immediately prior to the date of collection of the semen no equine animal has shown signs of infection with equine arteritis virus and of contagious equine metritis. II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen collection centre ⁽²⁾ which: II.3.1. is approved and listed by the competent authority of the third country or territory; II.3.2. complies with requirements as regards responsibilities, operational procedures, facilities and equipment set out in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/686. II.4. The semen described in Part I was obtained from donor animals which; II.4.1. were not vaccinated against African horse sickness at least in 40 days immediately prior to the date of collection of the semen; II.4.2. were not vaccinated against Venezuelan equine encephalomyelitis at least in 60 days immediately prior to the date of collection of the semen; II.4.3. remained for at least 3 months immediately prior to the date of collection of the semen in a third country or territory, or zone thereof referred to in box I.7; II.4.4. for at least 30 days immediately prior to the date of collection of the semen and during the collection period: II.4.4.1. were kept in establishments not situated in a restricted zone established due to the occurrence of African horse sickness, infection with Burkholderia mallei (glanders) or of an emerging disease relevant for equine animals; II.4.4.2. were kept in establishments where Venezuelan equine encephalomyelitis, dourine, surra (Trypanosoma evansi), equine infectious anaemia, contagious equine metritis (Taylorella equigenitalis), infection with rabies virus and anthrax have not been reported; II.4.4.3. were not in contact with animals from establishments situated in a restricted zone due to the occurrence of diseases referred to in point II.4.4.1 or from establishments which do not meet the conditions referred to in point II.4.4.2; II.4.5. were not used for natural breeding during at least 30 days immediately prior to the date of the first semen collection and between the dates of the first sample referred to in points II.4.8.1, II.4.8.2 and/or II.4.8.3. and until the end of the collection period; II.4.6. did not show symptoms of transmissible diseases on the date of admission to the semen collection centre and on the date of collection of the semen; II.4.7. are individually identified as provided for in Article 21(2) of Delegated Regulation (EU) 2020/692; II.4.8. have been subjected to the following tests, referred to in Part 4, Chapter I, point 1(a), of Annex II, to Delegated Regulation (EU) 2020/686, as follows: ⁽³⁾ II.4.8.1. for infection with equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result; II.4.8.2. for infection with equine arteritis virus (EVA), ⁽¹⁾ either [II.4.8.2.1. a serum neutralisation test with a negative result at a serum dilution of one in four;] ⁽¹⁾ and/or [II.4.8.2.2. a virus isolation test, polymerase chain reaction (PCR) or real-time PCR with a negative result on an aliquot of the entire semen of the donor stallion;] II.4.8.3. for contagious equine metritis (CEM), an agent identification test carried out on three specimens (swabs) taken from the donor stallion on two occasions with an interval of not less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis; The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor stallion and were placed in a transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory where they were subjected with a negative result to a test for: ⁽¹⁾ either [II.4.8.3.1. the isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport;] ⁽¹⁾ and/or [II.4.8.3.2. the detection of the genome of Taylorella equigenitalis by PCR or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal;] II.4.9. were subjected with the results specified in point II.4.8 in each case to at least one of the following testing programmes detailed in Part 4, Chapter I, points 1(b)(i), (ii) and (iii), of Annex II, to Delegated Regulation (EU) 2020/686: ⁽⁴⁾ [II.4.9.1. The donor stallion was continuously resident at the semen collection centre for at least 30 days immediately prior to the date of the first collection and during the period of collection of the semen described in Part I, and no equine animal in the semen collection centre came during that time into direct contact with equine animals of lower health status than the donor stallion. The tests described in point II.4.8 were carried out on samples taken ⁽⁵⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days immediately prior to the first semen collection.] ⁽⁴⁾ [II.4.9.2. The donor stallion was resident at the semen collection centre for at least 30 days immediately prior to the date of the first collection and during the period of collection of the semen described in Part I, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days during the collection period, or other equine animals in the semen collection centre came into direct contact with equine animals of a lower health status than the donor stallion. The tests described in point II.4.8 were carried out on samples taken ⁽⁵⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days immediately prior to the date of the first collection, and during the period of collection of the semen intended for the entry into the Union of fresh, chilled or frozen semen, the donor stallion was subjected to the tests described in point II.4.8, as follows: (a) for equine infectious anaemia, one of the tests described in point II.4.8.1 was last carried out on a sample of blood taken ⁽⁵⁾ not more than 90 days prior to the date of collection of the semen described in Part I; (b) for infection with equine arteritis virus, one of the tests described ⁽¹⁾ either [in point II.4.8.2 was last carried out on a sample taken ⁽⁵⁾ not more than 30 days immediately prior to the date of collection of the semen described in Part I;] ⁽¹⁾ or [in point II.4.8.2.2, in case the non-shedder state of a donor stallion seropositive for infection with equine arteritis virus is confirmed, was carried out on an aliquot of the entire semen of the donor stallion taken ⁽⁵⁾ not more than 6 months prior to the date of collection of the semen described in Part I, and a blood sample taken ⁽⁵⁾ from the donor stallion during the last 6 months reacted with a positive result in a serum neutralisation test for infection with equine arteritis virus at a serum dilution of more than one in four;] (c) for contagious equine metritis, the tests described in point II.4.8.3 were last carried out on three specimens (swabs) taken ⁽⁵⁾ not more than 60 days immediately prior to the date of the collection of the semen described in Part I ⁽¹⁾ either [on two occasions.]] ⁽¹⁾ or [on a single occasion and subjected to a PCR or real-time PCR.]] ⁽⁴⁾ [II.4.9.3. The donor stallion did not meet the conditions set out in Part 4, Chapter I, points 1(b)(i) and (ii), of Annex II to Delegated Regulation (EU) 2020/686 and the semen was collected for the entry into the Union as frozen semen. The tests described in points II.4.8.1, II.4.8.2 and II.4.8.3 were carried out on samples taken ⁽⁵⁾ from the donor stallion at least once a year at the beginning of the breeding season, and the tests described in points II.4.8.1 and II.4.8.3 were carried out on samples taken ⁽⁵⁾ from the donor stallion during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and prior to the date of removal of the semen from the semen collection centre, not less than 14 days and not more than 90 days after the date of collection of the semen described in Part I, and ⁽¹⁾ either [the tests for infection with equine arteritis virus described in point II.4.8.2 were carried out on samples taken ⁽⁵⁾ during the storage period of the semen of a minimum of 30 days from the date of the collection of the semen and prior to the date of removal of the semen from the semen collection centre or used, not less than 14 days and not more than 90 days after the date of the collection of the semen described in Part I.]] ⁽¹⁾ or [the non-shedder state of a donor stallion seropositive for infection with equine arteritis virus was confirmed by virus isolation test, PCR or real-time PCR carried out with a negative result on samples of an aliquot of the entire semen of the donor stallion taken ⁽⁵⁾ twice a year at an interval of at least 4 months, and the donor stallion reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for infection with equine arteritis virus.]] II.4.10. underwent the testing provided for in point II.4.9 on samples taken on the following dates: Identification of semen Test programme Start date ⁽⁵⁾ Date of sampling for health tests ⁽⁵⁾ Donor residence Semen collection EIA II.4.8.1 EVA II.4.8.2 CEM II.4.8.3 Blood sample Semen sample 1. sample 2. sample II.5. The semen described in Part I: II.5.1. has been collected, processed and stored in accordance with animal health requirements set out in Part 1, points 1 and 2, of Annex III to Delegated Regulation (EU) 2020/686; II.5.2. is placed in straws or other packages on which the mark is applied in accordance with requirements provided for in Article 83, point (a), of Delegated Regulation (EU) 2020/692 and that mark is indicated in box I.27; II.5.3. is transported in a container which: II.5.3.1. was sealed and numbered prior to the date of dispatch from the semen collection centre under responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the number as indicated in box I.19; II.5.3.2. has been cleaned and either disinfected or sterilised before use, or is single-use container; ^{(1) (6)} [II.5.3.3. has been filled in with a cryogenic agent which has not been previously used for other products.] ^{(1) (7)} [II.6. Where antibiotic(s) were added to the semen: II.6.1. The following antibiotic or mixture of antibiotics has been added to the semen after final dilution, or is contained in the used semen diluents: ⁽⁸⁾ … ; II.6.2. Immediately after the addition of the antibiotic(s), and before any possible freezing, the diluted semen was kept at a temperature of at least 5 °C, or under a time-temperature regime with a documented equivalent bactericidal activity.] Notes This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate the unique approval number and the name and address of the semen collection centre of dispatch of the consignment of semen. Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. “Test”: Indicate “Yes, see points II.4.9 and II.4.10”. Part II: Guidance for the completion of the table in point II.4.10: Abbreviations: EIA-1 Equine infectious anaemia (EIA) testing first occasion EIA-2 EIA testing second occasion EVA-B1 Infection with equine arteritis virus (EVA) testing on a blood sample first occasion EVA-B2 EVA testing on a blood sample second occasion EVA-S1 EVA testing on a semen sample first occasion EVA-S2 EVA testing on a semen sample second occasion CEM-11 Contagious equine metritis (CEM) testing first occasion first sample CEM-12 CEM testing first occasion second sample taken 7 days after CEM-11 CEM-21 CEM testing second occasion first sample CEM-22 CEM testing second occasion second sample taken 7 days after CEM-21 Instructions: For each semen identified in column A of the table and indicated in box I.27, the test programme (point II.4.9.1, II.4.9.2 and/or II.4.9.3) shall be specified in column B of the table, and columns C and D of the table shall be completed with the dates required. The dates when samples were taken for laboratory testing prior to the first collection of the semen described in Part I as required by points II.4.9.1, II.4.9.2 and II.4.9.3, shall be entered in the upper line of columns 5 to 9 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the example below. The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.9.2 or II.4.9.3 shall be entered in the lower line of columns 5 to 9 of the table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below. Identification of semen Test programme Start date Date of sampling for health tests Donor residence Semen collection EIA II.4.8.1 EVA II.4.8.2 CEM II.4.8.3 Blood sample Semen sample 1.sample 2.sample A B C D EIA-1 EVA-B1 EVA-S1 CEM-11 CEM-12 EIA-2 EVA-B2 EVA-S2 CEM-21 CEM-22 ⁽¹⁾ Delete if not applicable. ⁽²⁾ Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽³⁾ The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equine animals and their semen, oocytes and embryos were introduced into Iceland from outside prior to and during the period the semen was collected. ⁽⁴⁾ Cross out the programmes that do not apply to the consignment. ⁽⁵⁾ Insert date in table in point II.4.10 (follow guidance in Part II of the Notes). ⁽⁶⁾ Applicable for frozen semen. ⁽⁷⁾ Mandatory attestation in case antibiotic(s) were added. ⁽⁸⁾ Insert the name(s) of the antibiotic(s) added and its (their) concentration or the commercial name of the semen diluent containing antibiotic(s).


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 60 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC AFTER 30 SEPTEMBER 2014 AND BEFORE 21 APRIL 2021, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “EQUI-SEM-B-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model EQUI-SEM-B-ENTRY	Certificate model EQUI-SEM-B-ENTRY	Certificate model EQUI-SEM-B-ENTRY	Certificate model EQUI-SEM-B-ENTRY
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned, official veterinarian, of the exporting country ⁽¹⁾ … hereby certify that: (name of exporting country) II.1. The semen collection centre ⁽²⁾, in which the semen described in Part I was collected, processed and stored for export to the Union was approved and supervised by the competent authority in accordance with the conditions of Chapters I(I)(1) and I(II)(1) of Annex D to Directive 92/65/EEC ⁽³⁾; II.2. During the period commencing 30 days prior to the date of first collection of the semen described in Part I until the date the fresh or chilled semen was dispatched or until the 30 days storage period for frozen semen elapsed, the semen collection centre: II.2.1. was situated in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC ⁽⁴⁾, in that part of the territory of the exporting country which was: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for a period of at least 2 years, — free from glanders and dourine for a period of at least 6 months; II.2.2. fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in particular: ⁽⁵⁾ either [II.2.2.1. following a case of a disease mentioned below not all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the holding has been free: — from any type of equine encephalomyelitis for a period of at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, — from equine infectious anaemia (EIA) for at least the period required to obtain a negative result in an agar gel immunodiffusion test (AGID or Coggins test) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining animals, — from vesicular stomatitis (VS) for a period of at least 6 months from the last recorded case, — from rabies for a period of at least one month from the last recorded case, — from anthrax for a period of at least 15 days from the last recorded case,] ⁽⁵⁾ or [II.2.2.1. following a case of a disease mentioned below all the animals of species susceptible to that disease located in the holding have been slaughtered or killed and the premises disinfected, and the holding was free for a period of at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;] II.2.3. contained only equidae which were free of clinical signs of equine viral arteritis and contagious equine metritis, II.3. Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre: II.3.1. were continuously resident for a period of 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC, in that part of the territory of the exporting country which was during that period: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b), of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for a period of at least 2 years, — free from glanders and dourine for a period of at least 6 months; ⁽⁵⁾ either [II.3.2. originated from the country of export which was on the day of admission into the centre free from vesicular stomatitis (VS) for a period of at least 6 months,] ⁽⁵⁾ or [II.3.2. were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a negative result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result in accordance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE on a blood sample taken ⁽⁶⁾ within 14 days prior to entering the centre;] II.3.3. originated from holdings which on the day of admission onto the centre fulfilled the requirements of point II.2.2; II.4. The semen described in Part I was collected from donor stallions which: II.4.1. did not show any clinical sign of an infectious or contagious disease at the time of admission onto the semen collection centre and on the day the semen was collected; II.4.2. were kept for a period of at least 30 days prior to the date of semen collection in holdings where no equine animal has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period; II.4.3. were not used for natural mating during a period of at least 30 days prior to the date of first semen collection and between the dates of the first sample referred to in points II.4.5.1, II.4.5.2 and/or II.4.5.3 and until the end of the collection period; II.4.4. underwent the following tests, which meet at least the requirements of the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a laboratory which is recognised by the competent authority and has the tests referred to hereinafter included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 882/2004 ⁽⁷⁾, as follows: ⁽⁸⁾ [II.4.4.1. for equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result;] II.4.4.2. for equine viral arteritis (EVA), ⁽⁵⁾ either [II.4.4.2.1. a serum neutralisation test with a negative result at a serum dilution of one in four;] ⁽⁵⁾ and/or [II.4.4.2.2. a virus isolation test, polymerase chain reaction (PCR) or real-time PCR with a negative result on an aliquot of the entire semen of the donor stallion;] II.4.4.3. for contagious equine metritis (CEM), an agent identification test carried out on three specimens (swabs) taken from the donor stallion on two occasions with an interval of not less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis; The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor stallion and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory where they were subjected with a negative result to a test for: ⁽⁵⁾ either [II.4.4.3.1. the isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for a period of at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport;] ⁽⁵⁾ and/or [II.4.4.3.2. the detection of the genome of Taylorella equigenitalis by PCR or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal;] II.4.5. were subjected with the results specified in point II.4.4 in each case to at least one of the test programmes detailed respectively in points 1.6(a), (b) and (c) of Chapter II of Annex D to Directive 92/65/EEC as follows: ⁽⁹⁾ [II.4.5.1. The donor stallion was continuously resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, and no equidae on the semen collection centre came during that time into direct contact with equidae of lower health status than the donor stallion. The tests described in point II.4.4 were carried out on samples taken ⁽⁶⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the first collection of semen intended for imports into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days prior to the first semen collection.] ⁽⁹⁾ [II.4.5.2. The donor stallion was resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days, and/or other equidae on the semen collection centre came into direct contact with equidae of a lower health status. The tests described in point II.4.4 were carried out on samples taken ⁽⁶⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of semen intended for imports into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days prior to the first semen collection, and during the period of collection of the semen intended for imports into the Union of fresh, chilled or frozen semen the donor stallion was subjected to the tests described in point II.4.4, as follows: (a) for equine infectious anaemia, one of the tests described in point II.4.4.1 was last carried out on a sample of blood taken ⁽⁶⁾ not more than 90 days prior to the collection of the semen described in Part I; (b) for equine viral arteritis, one of the tests described ⁽⁵⁾ either [in point II.4.4.2 was last carried out on a sample taken ⁽⁶⁾ not more than 30 days prior to the date of the collection of the semen described In Part I;] ⁽⁵⁾ or [in point II.4.4.2.2 was carried out on an aliquot of the entire semen of the donor stallion taken ⁽⁶⁾ not more than 6 months prior to the date of the collection of the semen described in Part I and a blood sample taken ⁽⁶⁾ from the donor stallion during the 6 months period reacted with a positive result in a serum neutralisation test for equine viral arteritis at a serum dilution of more than one in four;] (c) for contagious equine metritis, the test described in point II.4.4.3 was last carried out on three specimens (swabs) taken ⁽⁶⁾ not more than 60 days prior to the date of the collection of semen described in Part I ⁽⁵⁾ either [on two occasions;] ⁽⁵⁾ or [on a single occasion and subjected to a PCR or real-time PCR.]] ⁽⁹⁾ [II.4.5.3. The donor stallion does not meet the conditions set out in points 1.6(a) and (b) of Chapter II of Annex D to Directive 92/65/EEC and the semen is collected for imports into the Union of frozen semen. The tests described in points II.4.4.1, II.4.4.2 and II.4.4.3 were carried out on samples taken ⁽⁶⁾ from the donor stallion at least once a year at the beginning of the breeding season, and the tests described in points II.4.4.1 and II.4.4.3 were carried out on samples taken ⁽⁶⁾ from the donor stallion during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre, not less than 14 days and not more than 90 days after the collection of the semen described in Part I, and ⁽⁵⁾ either [the tests for equine viral arteritis described in point II.4.4.2 were carried out on samples taken ⁽⁶⁾ during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre or used, not less than 14 days and not more than 90 days after the date of the collection of the semen described in Part I.] ⁽⁵⁾ or [the non-shedder state of a donor stallion seropositive for equine viral arteritis was confirmed by virus isolation test, PCR or real-time PCR carried out with a negative result on samples of an aliquot of the entire semen of the donor stallion taken ⁽⁶⁾ twice a year at an interval of at least 4 months and the donor stallion has reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for equine viral arteritis.]] II.4.6. underwent the testing provided for in points II.3.2 ⁽⁵⁾ and II.4.5 on samples taken on the following dates: Identification of semen Test programme Start date ⁽⁶⁾ Date of sampling for health tests ⁽⁶⁾ Donor residence Semen collection VS ⁽⁵⁾ II.3.2 EIAII.4.4.1 EVA II.4.4.2 CEM II.4.4.3 Blood sample Semen sample 1. sample 2. sample ⁽⁵⁾ either [II.5. No antibiotics were added to the semen;] ⁽⁵⁾ or [II.5. The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than ⁽¹⁰⁾: … … ;] II.6. The semen described in Part I was: II.6.1. collected, processed, stored and transported under conditions which comply with the requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC; II.6.2. sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in box I.19. Notes This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : ”Place of dispatch” shall correspond to the semen collection centre of the semen origin. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: Guidance for the completion of the table in point II.4.6 Abbreviations: VS Vesicular stomatitis (VS) testing if required in accordance with point II.3.2 EIA-1 Equine infectious anaemia (EIA) testing first occasion EIA-2 EIA testing second occasion EVA-B1 Equine viral arteritis (EVA) testing on a blood sample first occasion EVA-B2 EVA testing on a blood sample second occasion EVA-S1 EVA testing on a semen sample first occasion EVA-S2 EVA testing on a semen sample second occasion CEM-11 Contagious equine metritis (CEM) testing first occasion first sample CEM-12 CEM testing first occasion second sample taken 7 days after CEM-11 CEM-21 CEM testing second occasion first sample CEM-22 CEM testing second occasion second sample taken 7 days after CEM-21 Instructions: For each semen identified in column A of the table and indicated in box I.27, the test programme (points II.4.5.1, II.4.5.2 and/or II.4.5.3) shall be specified in column B of the table, and columns C and D of the table shall be completed with the dates required. The dates when samples were taken for laboratory testing prior to the first collection of the semen described in Part I as required by points II.4.5.1, II.4.5.2 and II.4.5.3, shall be entered in the upper line of columns 5 to 9 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the example below. The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.5.2 or II.4.5.3 shall be entered in the lower line of columns 5 to 9 of the table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below. Identification of semen Test programme Start date Date of sampling for health tests Donor residence Semen collection VSII.3.2 EIAII.4.4.1 EVA II.4.4.2 CEM II.4.4.3 Blood sample Semen sample 1.sample 2.sample A B C D VS EIA-1 EVA-B1 EVA-S1 CEM-11 CEM-12 EIA-2 EVA-B2 EVA-S2 CEM-21 CEM-22 ⁽¹⁾ Entry into the Union of equine semen is authorised from a third country or territory listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 provided that the semen was collected in the zone detailed in column 2 of the table in Part 1 of that Annex from a donor stallion of the category of equine animals indicated in column 3 of the table in Part 1 of that Annex. ⁽²⁾ Only semen collection centres listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽³⁾ Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268, 14.9.1992, p. 54). ⁽⁴⁾ Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1). ⁽⁵⁾ Delete if not applicable. ⁽⁶⁾ Insert date in table in point II.4.6 (follow guidance in Part II of the Notes). ⁽⁷⁾ Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (OJ L 165, 30.4.2004, p. 1). ⁽⁸⁾ The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equine animals and their semen, ova and embryos were introduced into Iceland from outside prior to and during the period the semen was collected. ⁽⁹⁾ Cross out the programmes that do not apply to the consignment. ⁽¹⁰⁾ Insert names and concentrations.

I, the undersigned, official veterinarian, of the exporting country ⁽¹⁾ … hereby certify that: (name of exporting country) II.1. The semen collection centre ⁽²⁾, in which the semen described in Part I was collected, processed and stored for export to the Union was approved and supervised by the competent authority in accordance with the conditions of Chapters I(I)(1) and I(II)(1) of Annex D to Directive 92/65/EEC ⁽³⁾; II.2. During the period commencing 30 days prior to the date of first collection of the semen described in Part I until the date the fresh or chilled semen was dispatched or until the 30 days storage period for frozen semen elapsed, the semen collection centre: II.2.1. was situated in the exporting country or, in the case of regionalisation according to Article 13 of Directive 2009/156/EC ⁽⁴⁾, in that part of the territory of the exporting country which was: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for a period of at least 2 years, — free from glanders and dourine for a period of at least 6 months; II.2.2. fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in particular: ⁽⁵⁾ either [II.2.2.1. following a case of a disease mentioned below not all the animals of species susceptible to that disease located in the holding were slaughtered or killed and the holding has been free: — from any type of equine encephalomyelitis for a period of at least 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, — from equine infectious anaemia (EIA) for at least the period required to obtain a negative result in an agar gel immunodiffusion test (AGID or Coggins test) carried out on samples taken after the infected animals were slaughtered on two occasions 3 months apart from each of the remaining animals, — from vesicular stomatitis (VS) for a period of at least 6 months from the last recorded case, — from rabies for a period of at least one month from the last recorded case, — from anthrax for a period of at least 15 days from the last recorded case,] ⁽⁵⁾ or [II.2.2.1. following a case of a disease mentioned below all the animals of species susceptible to that disease located in the holding have been slaughtered or killed and the premises disinfected, and the holding was free for a period of at least 30 days from any type of equine encephalomyelitis, equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning on the day on which following the destruction of the animals the disinfection of the premises was satisfactorily completed;] II.2.3. contained only equidae which were free of clinical signs of equine viral arteritis and contagious equine metritis, II.3. Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre: II.3.1. were continuously resident for a period of 3 months (or since entry if they were directly imported from a Member State during the 3 months period) in the exporting country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC, in that part of the territory of the exporting country which was during that period: — not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and (b), of Directive 2009/156/EC, — free from Venezuelan equine encephalomyelitis for a period of at least 2 years, — free from glanders and dourine for a period of at least 6 months; ⁽⁵⁾ either [II.3.2. originated from the country of export which was on the day of admission into the centre free from vesicular stomatitis (VS) for a period of at least 6 months,] ⁽⁵⁾ or [II.3.2. were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a negative result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result in accordance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE on a blood sample taken ⁽⁶⁾ within 14 days prior to entering the centre;] II.3.3. originated from holdings which on the day of admission onto the centre fulfilled the requirements of point II.2.2; II.4. The semen described in Part I was collected from donor stallions which: II.4.1. did not show any clinical sign of an infectious or contagious disease at the time of admission onto the semen collection centre and on the day the semen was collected; II.4.2. were kept for a period of at least 30 days prior to the date of semen collection in holdings where no equine animal has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period; II.4.3. were not used for natural mating during a period of at least 30 days prior to the date of first semen collection and between the dates of the first sample referred to in points II.4.5.1, II.4.5.2 and/or II.4.5.3 and until the end of the collection period; II.4.4. underwent the following tests, which meet at least the requirements of the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a laboratory which is recognised by the competent authority and has the tests referred to hereinafter included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 882/2004 ⁽⁷⁾, as follows: ⁽⁸⁾ [II.4.4.1. for equine infectious anaemia (EIA), an agar-gel immuno-diffusion test (AGID or Coggins test) or an enzyme-linked immunosorbent assay (ELISA) with a negative result;] II.4.4.2. for equine viral arteritis (EVA), ⁽⁵⁾ either [II.4.4.2.1. a serum neutralisation test with a negative result at a serum dilution of one in four;] ⁽⁵⁾ and/or [II.4.4.2.2. a virus isolation test, polymerase chain reaction (PCR) or real-time PCR with a negative result on an aliquot of the entire semen of the donor stallion;] II.4.4.3. for contagious equine metritis (CEM), an agent identification test carried out on three specimens (swabs) taken from the donor stallion on two occasions with an interval of not less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis; The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the donor stallion and were placed in transport medium with activated charcoal, such as Amies medium, before dispatch to the laboratory where they were subjected with a negative result to a test for: ⁽⁵⁾ either [II.4.4.3.1. the isolation of Taylorella equigenitalis after cultivation under microaerophilic conditions for a period of at least 7 days, set up within 24 hours after taking the specimens from the donor animal, or 48 hours where the specimens are kept cool during transport;] ⁽⁵⁾ and/or [II.4.4.3.2. the detection of the genome of Taylorella equigenitalis by PCR or real-time PCR, carried out within 48 hours after taking the specimens from the donor animal;] II.4.5. were subjected with the results specified in point II.4.4 in each case to at least one of the test programmes detailed respectively in points 1.6(a), (b) and (c) of Chapter II of Annex D to Directive 92/65/EEC as follows: ⁽⁹⁾ [II.4.5.1. The donor stallion was continuously resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, and no equidae on the semen collection centre came during that time into direct contact with equidae of lower health status than the donor stallion. The tests described in point II.4.4 were carried out on samples taken ⁽⁶⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the first collection of semen intended for imports into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days prior to the first semen collection.] ⁽⁹⁾ [II.4.5.2. The donor stallion was resident on the semen collection centre for a period of at least 30 days prior to the date of the first collection and during the period of collection of the semen described in Part I, but left the semen collection centre under the responsibility of the centre veterinarian for a continuous period of less than 14 days, and/or other equidae on the semen collection centre came into direct contact with equidae of a lower health status. The tests described in point II.4.4 were carried out on samples taken ⁽⁶⁾ from the donor stallion at least once a year at the beginning of the breeding season or prior to the date of the first collection of semen intended for imports into the Union of fresh, chilled or frozen semen and not less than 14 days following the date of the commencement of the residence period of at least 30 days prior to the first semen collection, and during the period of collection of the semen intended for imports into the Union of fresh, chilled or frozen semen the donor stallion was subjected to the tests described in point II.4.4, as follows: (a) for equine infectious anaemia, one of the tests described in point II.4.4.1 was last carried out on a sample of blood taken ⁽⁶⁾ not more than 90 days prior to the collection of the semen described in Part I; (b) for equine viral arteritis, one of the tests described ⁽⁵⁾ either [in point II.4.4.2 was last carried out on a sample taken ⁽⁶⁾ not more than 30 days prior to the date of the collection of the semen described In Part I;] ⁽⁵⁾ or [in point II.4.4.2.2 was carried out on an aliquot of the entire semen of the donor stallion taken ⁽⁶⁾ not more than 6 months prior to the date of the collection of the semen described in Part I and a blood sample taken ⁽⁶⁾ from the donor stallion during the 6 months period reacted with a positive result in a serum neutralisation test for equine viral arteritis at a serum dilution of more than one in four;] (c) for contagious equine metritis, the test described in point II.4.4.3 was last carried out on three specimens (swabs) taken ⁽⁶⁾ not more than 60 days prior to the date of the collection of semen described in Part I ⁽⁵⁾ either [on two occasions;] ⁽⁵⁾ or [on a single occasion and subjected to a PCR or real-time PCR.]] ⁽⁹⁾ [II.4.5.3. The donor stallion does not meet the conditions set out in points 1.6(a) and (b) of Chapter II of Annex D to Directive 92/65/EEC and the semen is collected for imports into the Union of frozen semen. The tests described in points II.4.4.1, II.4.4.2 and II.4.4.3 were carried out on samples taken ⁽⁶⁾ from the donor stallion at least once a year at the beginning of the breeding season, and the tests described in points II.4.4.1 and II.4.4.3 were carried out on samples taken ⁽⁶⁾ from the donor stallion during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre, not less than 14 days and not more than 90 days after the collection of the semen described in Part I, and ⁽⁵⁾ either [the tests for equine viral arteritis described in point II.4.4.2 were carried out on samples taken ⁽⁶⁾ during the storage period of the semen of a minimum period of 30 days from the date of the collection of the semen and before the semen is removed from the semen collection centre or used, not less than 14 days and not more than 90 days after the date of the collection of the semen described in Part I.] ⁽⁵⁾ or [the non-shedder state of a donor stallion seropositive for equine viral arteritis was confirmed by virus isolation test, PCR or real-time PCR carried out with a negative result on samples of an aliquot of the entire semen of the donor stallion taken ⁽⁶⁾ twice a year at an interval of at least 4 months and the donor stallion has reacted with a positive result at a serum dilution of at least one in four in a serum neutralisation test for equine viral arteritis.]] II.4.6. underwent the testing provided for in points II.3.2 ⁽⁵⁾ and II.4.5 on samples taken on the following dates: Identification of semen Test programme Start date ⁽⁶⁾ Date of sampling for health tests ⁽⁶⁾ Donor residence Semen collection VS ⁽⁵⁾ II.3.2 EIAII.4.4.1 EVA II.4.4.2 CEM II.4.4.3 Blood sample Semen sample 1. sample 2. sample ⁽⁵⁾ either [II.5. No antibiotics were added to the semen;] ⁽⁵⁾ or [II.5. The following antibiotic or combination of antibiotics was added to produce a concentration in the final diluted semen of not less than ⁽¹⁰⁾: … … ;] II.6. The semen described in Part I was: II.6.1. collected, processed, stored and transported under conditions which comply with the requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC; II.6.2. sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in box I.19. Notes This animal health certificate is intended for the entry into the Union of semen of equine animals, including when the Union is not the final destination of the semen. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : ”Place of dispatch” shall correspond to the semen collection centre of the semen origin. Box reference I.12 : “Place of destination”: Indicate the address and unique registration or approval number of the establishment of destination of the consignment of semen. Box reference I.19 : Seal number shall be indicated. Box reference I.24 : Total number of packages shall correspond to the number of containers. Box reference I.27 : “Type”: Indicate semen. “Identification number”: Indicate the identification number of each donor animal. “Identification mark”: Indicate the mark on the straw or other packages where semen of the consignment is placed. “Date of collection/production”: Indicate the date on which semen of the consignment was collected in the following format: dd.mm.yyyy. “Approval or registration number of plant/establishment/centre”: Indicate the unique approval number of the semen collection centre where the semen of the consignment was collected. “Quantity”: Indicate the number of straws or other packages with the same mark. Part II: Guidance for the completion of the table in point II.4.6 Abbreviations: VS Vesicular stomatitis (VS) testing if required in accordance with point II.3.2 EIA-1 Equine infectious anaemia (EIA) testing first occasion EIA-2 EIA testing second occasion EVA-B1 Equine viral arteritis (EVA) testing on a blood sample first occasion EVA-B2 EVA testing on a blood sample second occasion EVA-S1 EVA testing on a semen sample first occasion EVA-S2 EVA testing on a semen sample second occasion CEM-11 Contagious equine metritis (CEM) testing first occasion first sample CEM-12 CEM testing first occasion second sample taken 7 days after CEM-11 CEM-21 CEM testing second occasion first sample CEM-22 CEM testing second occasion second sample taken 7 days after CEM-21 Instructions: For each semen identified in column A of the table and indicated in box I.27, the test programme (points II.4.5.1, II.4.5.2 and/or II.4.5.3) shall be specified in column B of the table, and columns C and D of the table shall be completed with the dates required. The dates when samples were taken for laboratory testing prior to the first collection of the semen described in Part I as required by points II.4.5.1, II.4.5.2 and II.4.5.3, shall be entered in the upper line of columns 5 to 9 of the table, this being the boxes marked with EIA-1, EVA-B1 or EVA-S1 and CEM-11 and CEM-12 in the example below. The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.5.2 or II.4.5.3 shall be entered in the lower line of columns 5 to 9 of the table, this being the boxes EIA-2, EVA-B2 or EVA-S2 and CEM-21 and CEM-22 in the example below. Identification of semen Test programme Start date Date of sampling for health tests Donor residence Semen collection VSII.3.2 EIAII.4.4.1 EVA II.4.4.2 CEM II.4.4.3 Blood sample Semen sample 1.sample 2.sample A B C D VS EIA-1 EVA-B1 EVA-S1 CEM-11 CEM-12 EIA-2 EVA-B2 EVA-S2 CEM-21 CEM-22 ⁽¹⁾ Entry into the Union of equine semen is authorised from a third country or territory listed in column 1 of the table in Part 1 of Annex XII to Commission Implementing Regulation (EU) 2021/404 provided that the semen was collected in the zone detailed in column 2 of the table in Part 1 of that Annex from a donor stallion of the category of equine animals indicated in column 3 of the table in Part 1 of that Annex. ⁽²⁾ Only semen collection centres listed in accordance with Article 17(3), point (b), of Directive 92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en. ⁽³⁾ Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and imports into the Community of animals, semen, ova and embryos not subject to animal health requirements laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268, 14.9.1992, p. 54). ⁽⁴⁾ Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1). ⁽⁵⁾ Delete if not applicable. ⁽⁶⁾ Insert date in table in point II.4.6 (follow guidance in Part II of the Notes). ⁽⁷⁾ Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (OJ L 165, 30.4.2004, p. 1). ⁽⁸⁾ The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not required for donor equine animals which continuously resided in Iceland since birth, provided that Iceland remained officially free of equine infectious anaemia and no equine animals and their semen, ova and embryos were introduced into Iceland from outside prior to and during the period the semen was collected. ⁽⁹⁾ Cross out the programmes that do not apply to the consignment. ⁽¹⁰⁾ Insert names and concentrations.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 61 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF CONSIGNMENTS OF STOCKS OF SEMEN OF EQUINE ANIMALS COLLECTED, PROCESSED AND STORED IN ACCORDANCE WITH COUNCIL DIRECTIVE 92/65/EEC AFTER 31 AUGUST 2010 AND BEFORE 1 OCTOBER 2014, DISPATCHED AFTER 20 APRIL 2021 FROM THE SEMEN COLLECTION CENTRE WHERE THE SEMEN WAS COLLECTED (MODEL “EQUI-SEM-C-ENTRY”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification

---	---
I.18	Transport conditions
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21	☐ For transit
	Third country

---	---
I.24	Total number of packages

---	---
I.27	Description of consignment
CN code	Species

Type

Part II: Certification


COUNTRY	COUNTRY	Certificate model EQUI-SEM-C-ENTRY	Certificate model EQUI-SEM-C-ENTRY	Certificate model EQUI-SEM-C-ENTRY	Certificate model EQUI-SEM-C-ENTRY
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.